The benefit and risk of addition of chemotherapy to EGFR tyrosine kinase inhibitors for EGFR-positive non-small cell lung cancer patients with brain metastases: a meta-analysis based on randomized controlled trials - Chen, Zhigang; Fu, Xiang; Zhu, Lingping; Wen, Xiurong (Frontiers in Oncology, 2024)